- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02082561
False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders
Study Overview
Status
Intervention / Treatment
Detailed Description
The aim of the current study was to test the efficacy of an individually administered, brief (5-session) transdiagnostic treatment for anxiety disorders. The current treatment (called F-SET) focuses chiefly on the elimination of anxiety maintaining behaviors and cognitive strategies (so-called "safety" aids) among individuals suffering from a range of anxiety disorders including generalized anxiety disorder (GAD), social anxiety disorder (SAD) and panic disorder (PD).
Four primary hypotheses were evaluated in the current study: (1) the F-SET protocol would produce better overall outcome relative to a waitlist control, (2) the F-SET protocol would yield clinically significant improvement of primary diagnosis symptoms as well as secondary diagnosis symptoms, (3) the F-SET protocol would create treatment improvement that is maintained during a 1 month follow-up interval and (4) given that reduction of safety aid use is the key mechanism of change in the F-SET treatment, a reduction in safety aid use will mediate the relationship between pre and post treatment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Florida State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants must have a primary diagnosis of panic disorder, generalized anxiety disorder, or social anxiety disorder.
- No change in medication type or dose during the 12 weeks prior to treatment
Exclusion Criteria:
- Current or past schizophrenia, bipolar disorder, or organic mental disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Transdiagnostic Treatment (F-SET)
F-SET treatment consisted of five weekly individual sessions (approximately 50 minutes each).
The F-SET protocol is consistent with current CBT protocols for anxiety disorders.
|
F-SET treatment consisted of five weekly individual sessions (approximately 50 minutes each).
The participants learn to techniques and skills to help them reduce their anxiety.
F-SET protocol is consistent with current CBT protocols for anxiety disorders.
|
NO_INTERVENTION: Waitlist
The waitlist control condition was comprised of patients randomly assigned to the waitlist condition (WL).
Individuals in this condition were reassessed after five weeks and were then offered treatment, but were no longer followed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Structured Clinical Interview for the DSM-IV
Time Frame: One Month Follow-up
|
Structured Clinical Interview for the DSM-IV (SCID-IV).
The SCID-IV (Spitzer, Gibbon, & Williams, 1996) is a structured diagnostic interview designed to provide detailed coverage of Axis-I disorders.
The SCID-IV has been shown to be a reliable and valid measure of the Diagnostic and Statistical Manual of Mental Disorders (fourth edition-text revision; American Psychiatric Association, 2000) Axis I disorders (Zanarini et al., 2000).
|
One Month Follow-up
|
Clinician Global Impressions Scale (CGI) - Severity of Illness Subscale
Time Frame: One Month Follow-up
|
Clinician Global Impressions Scale (CGI) - Severity of Illness Subscale.
The CGI (Guy, 1976) is a widely used clinician-rated measure of global impressions.
The severity of illness subscale from the CGI is composed of a 7-point scale (ranging from 0=not at all ill to 6=among the most extremely ill patients) and is used to assess
|
One Month Follow-up
|
Work and Social Adjustment Scale (WSAS)
Time Frame: One Month Follow-up
|
Work and Social Adjustment Scale (WSAS).
The WSAS is a 5-item descriptive measure of subjective interference in various life domains (i.e., work, home management, private leisure, and family relationships).
Interference in the past week is rated from 0 (not at all interfering) to 8 (severe interference).
The WSAS has demonstrated good internal consistency and has been successfully used in previous studies (e.g., Brown & Barlow, 1995; Ellard, Fairholme, Boisseau, Farchione, & Barlow, 2010).
The WSAS was used as an index of overall disability and impairment.
The WSAS demonstrated good internal consistency in the present sample (mean inter-item correlation = .28).
|
One Month Follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Norman B Schmidt, Ph.D, Florida State University
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Florida State University
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
-
Xijing HospitalRecruitingGeneralized Anxiety DisorderChina
-
Sichuan Jishengtang Pharmaceutical Co., Ltd.Not yet recruitingGeneralized Anxiety Disorder
-
Hospital de Clinicas de Porto AlegreRecruitingGeneralized Anxiety DisorderBrazil
-
University of California, Los AngelesMedical University of South Carolina; Massachusetts General HospitalRecruitingGeneralized Anxiety DisorderUnited States
-
Shahid Beheshti University of Medical SciencesCompletedGeneralized Anxiety DisorderIran, Islamic Republic of
-
Dr. Nazanin AlaviOnline PsychoTherapy ClinicCompletedGeneralized Anxiety DisorderCanada
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH)CompletedGeneralized Anxiety DisorderUnited States
-
The Canadian College of Naturopathic MedicineMassachusetts General Hospital; McGill University; Mitacs; Ekhagastiftelsen; Netherlands... and other collaboratorsActive, not recruitingGeneralized Anxiety DisorderCanada
Clinical Trials on Transdiagnostic Treatment (F-SET)
-
Universitat Jaume ICompleted
-
Universidad Autonoma de Baja CaliforniaUniversidad Autonoma de Ciudad JuarezCompleted
-
University of OtagoCanterbury Medical Research FoundationNot yet recruitingPsychological Distress | Trauma, Psychological | Emotional ProblemNew Zealand
-
Universitat Jaume ICompletedDepressive Disorder | Anxiety DisordersSpain
-
Luleå Tekniska UniversitetRegion NorrbottenRecruitingDepression | Anxiety Disorders | Stress DisorderSweden
-
Duke UniversityCompletedMisophoniaUnited States
-
Instituto de Investigación Sanitaria AragónRecruitingDepressive Disorder | Anxiety Disorders | Emotional Disorder | Post COVID-19 ConditionSpain
-
University of IcelandPrimary Health Care Clinic, Reykjavik, IcelandRecruitingDepressive Disorder | Depression | Anxiety Disorders | AnxietyIceland
-
Universidad de CórdobaMinisterio de Economía y Competitividad, SpainCompletedEmotional DisorderSpain
-
Fundació Sant Joan de DéuParc Sanitari Sant Joan de DéuRecruitingPsychosis | Emotional DysfunctionSpain